This suggests that mineralocorticoid receptor antagonist(MRA)could be a useful treatment for slowing the progression of chronic kidney disease(CKD).Patients with CKD and chronic heart failure are strongly advised to use steroidal MRA. Here, NR3C2 is linked to chronic kidney disease.